Capital Asset Pricing Model (CAPM)
Capital asset pricing model (CAPM) indicates what should be the expected or required rate of return on risky assets like AbbVie Inc. common stock.
Paying user area
Try for free
AbbVie Inc. pages available for free this week:
- Balance Sheet: Liabilities and Stockholders’ Equity
- Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
- Analysis of Short-term (Operating) Activity Ratios
- DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
- Common Stock Valuation Ratios
- Selected Financial Data since 2012
- Net Profit Margin since 2012
- Return on Assets (ROA) since 2012
- Price to Earnings (P/E) since 2012
- Analysis of Revenues
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to AbbVie Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Rates of Return
AbbVie Inc., monthly rates of return
| AbbVie Inc. (ABBV) | Standard & Poor’s 500 (S&P 500) | |||||
|---|---|---|---|---|---|---|
| t | Date | PriceABBV,t1 | DividendABBV,t1 | RABBV,t2 | PriceS&P 500,t | RS&P 500,t3 |
| Jan 31, 2020 | ||||||
| 1. | Feb 29, 2020 | |||||
| 2. | Mar 31, 2020 | |||||
| 3. | Apr 30, 2020 | |||||
| . | . | . | . | . | . | . |
| . | . | . | . | . | . | . |
| . | . | . | . | . | . | . |
| 58. | Nov 30, 2024 | |||||
| 59. | Dec 31, 2024 | |||||
| Average (R): | ||||||
| Standard deviation: | ||||||
| AbbVie Inc. (ABBV) | Standard & Poor’s 500 (S&P 500) | |||||
|---|---|---|---|---|---|---|
| t | Date | PriceABBV,t1 | DividendABBV,t1 | RABBV,t2 | PriceS&P 500,t | RS&P 500,t3 |
| Jan 31, 2020 | ||||||
| 1. | Feb 29, 2020 | |||||
| 2. | Mar 31, 2020 | |||||
| 3. | Apr 30, 2020 | |||||
| 4. | May 31, 2020 | |||||
| 5. | Jun 30, 2020 | |||||
| 6. | Jul 31, 2020 | |||||
| 7. | Aug 31, 2020 | |||||
| 8. | Sep 30, 2020 | |||||
| 9. | Oct 31, 2020 | |||||
| 10. | Nov 30, 2020 | |||||
| 11. | Dec 31, 2020 | |||||
| 12. | Jan 31, 2021 | |||||
| 13. | Feb 28, 2021 | |||||
| 14. | Mar 31, 2021 | |||||
| 15. | Apr 30, 2021 | |||||
| 16. | May 31, 2021 | |||||
| 17. | Jun 30, 2021 | |||||
| 18. | Jul 31, 2021 | |||||
| 19. | Aug 31, 2021 | |||||
| 20. | Sep 30, 2021 | |||||
| 21. | Oct 31, 2021 | |||||
| 22. | Nov 30, 2021 | |||||
| 23. | Dec 31, 2021 | |||||
| 24. | Jan 31, 2022 | |||||
| 25. | Feb 28, 2022 | |||||
| 26. | Mar 31, 2022 | |||||
| 27. | Apr 30, 2022 | |||||
| 28. | May 31, 2022 | |||||
| 29. | Jun 30, 2022 | |||||
| 30. | Jul 31, 2022 | |||||
| 31. | Aug 31, 2022 | |||||
| 32. | Sep 30, 2022 | |||||
| 33. | Oct 31, 2022 | |||||
| 34. | Nov 30, 2022 | |||||
| 35. | Dec 31, 2022 | |||||
| 36. | Jan 31, 2023 | |||||
| 37. | Feb 28, 2023 | |||||
| 38. | Mar 31, 2023 | |||||
| 39. | Apr 30, 2023 | |||||
| 40. | May 31, 2023 | |||||
| 41. | Jun 30, 2023 | |||||
| 42. | Jul 31, 2023 | |||||
| 43. | Aug 31, 2023 | |||||
| 44. | Sep 30, 2023 | |||||
| 45. | Oct 31, 2023 | |||||
| 46. | Nov 30, 2023 | |||||
| 47. | Dec 31, 2023 | |||||
| 48. | Jan 31, 2024 | |||||
| 49. | Feb 29, 2024 | |||||
| 50. | Mar 31, 2024 | |||||
| 51. | Apr 30, 2024 | |||||
| 52. | May 31, 2024 | |||||
| 53. | Jun 30, 2024 | |||||
| 54. | Jul 31, 2024 | |||||
| 55. | Aug 31, 2024 | |||||
| 56. | Sep 30, 2024 | |||||
| 57. | Oct 31, 2024 | |||||
| 58. | Nov 30, 2024 | |||||
| 59. | Dec 31, 2024 | |||||
| Average (R): | ||||||
| Standard deviation: | ||||||
Show all
1 Data in US$ per share of common stock, adjusted for splits and stock dividends.
2 Rate of return on common stock of ABBV during period t
3 Rate of return on S&P 500 (the market portfolio proxy) during period t
Variance and Covariance
AbbVie Inc., calculation of variance and covariance of returns
| t | Date | RABBV,t | RS&P 500,t | (RABBV,t–RABBV)2 | (RS&P 500,t–RS&P 500)2 | (RABBV,t–RABBV)×(RS&P 500,t–RS&P 500) |
|---|---|---|---|---|---|---|
| 1. | Feb 29, 2020 | |||||
| 2. | Mar 31, 2020 | |||||
| 3. | Apr 30, 2020 | |||||
| . | . | . | . | . | . | . |
| . | . | . | . | . | . | . |
| . | . | . | . | . | . | . |
| 58. | Nov 30, 2024 | |||||
| 59. | Dec 31, 2024 | |||||
| Total (Σ): | ||||||
| t | Date | RABBV,t | RS&P 500,t | (RABBV,t–RABBV)2 | (RS&P 500,t–RS&P 500)2 | (RABBV,t–RABBV)×(RS&P 500,t–RS&P 500) |
|---|---|---|---|---|---|---|
| 1. | Feb 29, 2020 | |||||
| 2. | Mar 31, 2020 | |||||
| 3. | Apr 30, 2020 | |||||
| 4. | May 31, 2020 | |||||
| 5. | Jun 30, 2020 | |||||
| 6. | Jul 31, 2020 | |||||
| 7. | Aug 31, 2020 | |||||
| 8. | Sep 30, 2020 | |||||
| 9. | Oct 31, 2020 | |||||
| 10. | Nov 30, 2020 | |||||
| 11. | Dec 31, 2020 | |||||
| 12. | Jan 31, 2021 | |||||
| 13. | Feb 28, 2021 | |||||
| 14. | Mar 31, 2021 | |||||
| 15. | Apr 30, 2021 | |||||
| 16. | May 31, 2021 | |||||
| 17. | Jun 30, 2021 | |||||
| 18. | Jul 31, 2021 | |||||
| 19. | Aug 31, 2021 | |||||
| 20. | Sep 30, 2021 | |||||
| 21. | Oct 31, 2021 | |||||
| 22. | Nov 30, 2021 | |||||
| 23. | Dec 31, 2021 | |||||
| 24. | Jan 31, 2022 | |||||
| 25. | Feb 28, 2022 | |||||
| 26. | Mar 31, 2022 | |||||
| 27. | Apr 30, 2022 | |||||
| 28. | May 31, 2022 | |||||
| 29. | Jun 30, 2022 | |||||
| 30. | Jul 31, 2022 | |||||
| 31. | Aug 31, 2022 | |||||
| 32. | Sep 30, 2022 | |||||
| 33. | Oct 31, 2022 | |||||
| 34. | Nov 30, 2022 | |||||
| 35. | Dec 31, 2022 | |||||
| 36. | Jan 31, 2023 | |||||
| 37. | Feb 28, 2023 | |||||
| 38. | Mar 31, 2023 | |||||
| 39. | Apr 30, 2023 | |||||
| 40. | May 31, 2023 | |||||
| 41. | Jun 30, 2023 | |||||
| 42. | Jul 31, 2023 | |||||
| 43. | Aug 31, 2023 | |||||
| 44. | Sep 30, 2023 | |||||
| 45. | Oct 31, 2023 | |||||
| 46. | Nov 30, 2023 | |||||
| 47. | Dec 31, 2023 | |||||
| 48. | Jan 31, 2024 | |||||
| 49. | Feb 29, 2024 | |||||
| 50. | Mar 31, 2024 | |||||
| 51. | Apr 30, 2024 | |||||
| 52. | May 31, 2024 | |||||
| 53. | Jun 30, 2024 | |||||
| 54. | Jul 31, 2024 | |||||
| 55. | Aug 31, 2024 | |||||
| 56. | Sep 30, 2024 | |||||
| 57. | Oct 31, 2024 | |||||
| 58. | Nov 30, 2024 | |||||
| 59. | Dec 31, 2024 | |||||
| Total (Σ): | ||||||
Show all
VarianceABBV = Σ(RABBV,t–RABBV)2 ÷ (59 – 1)
= ÷ (59 – 1)
=
VarianceS&P 500 = Σ(RS&P 500,t–RS&P 500)2 ÷ (59 – 1)
= ÷ (59 – 1)
=
CovarianceABBV, S&P 500 = Σ(RABBV,t–RABBV)×(RS&P 500,t–RS&P 500) ÷ (59 – 1)
= ÷ (59 – 1)
=
Systematic Risk (β) Estimation
| VarianceABBV | |
| VarianceS&P 500 | |
| CovarianceABBV, S&P 500 | |
| Correlation coefficientABBV, S&P 5001 | |
| βABBV2 | |
| αABBV3 |
Calculations
1 Correlation coefficientABBV, S&P 500
= CovarianceABBV, S&P 500 ÷ (Standard deviationABBV × Standard deviationS&P 500)
= ÷ ( × )
=
2 βABBV
= CovarianceABBV, S&P 500 ÷ VarianceS&P 500
= ÷
=
3 αABBV
= AverageABBV – βABBV × AverageS&P 500
= – ×
=
Expected Rate of Return
| Assumptions | ||
| Rate of return on LT Treasury Composite1 | RF | |
| Expected rate of return on market portfolio2 | E(RM) | |
| Systematic risk (β) of AbbVie Inc. common stock | βABBV | |
| Expected rate of return on AbbVie Inc. common stock3 | E(RABBV) | |
1 Unweighted average of bid yields on all outstanding fixed-coupon U.S. Treasury bonds neither due or callable in less than 10 years (risk-free rate of return proxy).
3 E(RABBV) = RF + βABBV [E(RM) – RF]
= + [ – ]
=